Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 18
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Chemotherapy with AMSA vs Immunotherapy with Poly-ICLC as Maintenance Therapy for Acute Nonlymphocytic Leukemia in Second Remission
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
over 18
UMCC-8038
2.
Phase I-II Immunotherapy with Poly ICLC for Multiple Myeloma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
MDA-M-8002
3.
Phase I/II Immunotherapy with Poly-ICLC for Recurrent Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
NCI
EST-PC-680
4.
Phase II Immunotherapy with Stabilized Poly-IC (Poly-ICLC) in the Treatment of Refractory Pediatric Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 18
NCI-79-C-23
NCI-POB-7803
5.
Phase II Study of Human Lymphoblastoid Interferon vs Stabilized Poly-IC (Poly-ICLC) for Acute Myelocytic Leukemia, CLL, and Various Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
NCI-79-C-80
NCI-POB-7901, UMCC-7914
6.
Phase II Immunotherapy with Stabilized Poly-IC (Poly-ICLC) for Previously Treated Children with Acute Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 21
NCI
CCG-082
7.
Phase II Immunotherapy with Poly ICLC for Refractory Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MDA-MBDT-8027
8.
Phase II Immunotherapy with Poly-ICLC for Children with Metastatic Neuroblastoma Refractory to Standard Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 21
NCI
CCG-082A
Last Modified:
4/26/2007
9.
Phase II Immunotherapy with the Interferon Inducer Poly ICLC in Patients with Unresectable Renal Cell Cancer (Summary Last Modified 07/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
EST-PA-884
EST-P-A884
Last Modified:
8/1/1988
10.
Phase II Immunotherapy with the Interferon Inducer Poly ICLC in Patients with Relapsed Lymphoma, Hodgkin's Disease, or Cutaneous T-Cell Lymphoma (Summary Last Modified 08/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
EST-PB-484
EST-P-B484
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute